Finally, pre‐incubation with integrin ανβ3 neutralizing antibody abrogated PLC, PKC and c‐Src activation in response to TSP‐2 in osteosarcoma cells (Figure S2). The gene discussed is PRRT2; the disease is osteosarcoma.